Granted Patent
Utility
US 6,573,281 · App. 09/958,439
Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders
Inventors:
Xavier Emonds-Alt, Philippe Soubrie, Régis Steinberg
Patented Case
View Patent ↗
Granted: Jun 3, 2003
Filed: Oct 9, 2001
Inventors
Xavier Emonds-Alt
Philippe Soubrie
Régis Steinberg
Assignee (at issue)
Sanofi-Synthelabo
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.